CSCIF (Cosciens Biopharma) Change In Inventory: $0.84 Mil (TTM As of Mar. 2026)


CSCIF Cosciens Biopharma Inc CSCIF
49 GF Score
Price $7.35
GF Value $6.65
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cosciens Biopharma Change In Inventory?

Cosciens Biopharma CSCIF +6.52% 49 Change In Inventory is $0.84 Mil as of Mar. 2026. GuruFocus rates CSCIF with a GF Score™ of 49/100 and a GF Value™ of $6.65 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Cosciens Biopharma's change in inventory for the quarter that ended in Mar. 2026 was $0.14 Mil. It means Cosciens Biopharma's inventory declined by $0.14 Mil from Dec. 2025 to Mar. 2026 .

Cosciens Biopharma's change in inventory for the fiscal year that ended in Dec. 2025 was $0.00 Mil. It means Cosciens Biopharma's inventory stayed the same from Dec. 2024 to Dec. 2025 .

Cosciens Biopharma's Total Inventories for the quarter that ended in Mar. 2026 was $1.10 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cosciens Biopharma's Days Inventory for the quarter that ended in Mar. 2026 was 100.25.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cosciens Biopharma's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.91.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cosciens Biopharma's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.64.

Cosciens Biopharma  (OTCPK:CSCIF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cosciens Biopharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=1.203/1.095*365 / 4
=100.25

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cosciens Biopharma's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1.095 / 1.203
=0.91

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cosciens Biopharma's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=1.203 / 1.888
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosciens Biopharma Change In Inventory Related Terms

Cosciens Biopharma Change In Inventory Historical Data

* Premium members only.

The historical data trend for Cosciens Biopharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosciens Biopharma Change In Inventory Chart

Cosciens Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.87 -1.06 -1.17 0.00 0.00

Cosciens Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.77 -0.06 0.00 0.14
CSCIF
49GF Score
Cosciens Biopharma Inc CSCIF
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosciens Biopharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.84 Mil mean?
Cosciens Biopharma (CSCIF) has a Change In Inventory of $0.84 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cosciens Biopharma and its competitors.
Is Cosciens Biopharma's Change In Inventory too high?
Cosciens Biopharma's current Change In Inventory is $0.84 Mil. Overall, Cosciens Biopharma has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cosciens Biopharma's Change In Inventory compare to VRTX and REGN?
Cosciens Biopharma's Change In Inventory of $0.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cosciens Biopharma and its competitors. Cosciens Biopharma's current Change In Inventory is $0.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosciens Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Cosciens Biopharma (CSCIF) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.65, compared to a current price of $7.35 — trading 10.5% above its estimated fair value. The current Change In Inventory is $0.84 Mil. Cosciens Biopharma's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Cosciens Biopharma (CSCIF), the current Change In Inventory is $0.84 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosciens Biopharma (CSCIF) Overvalued in 2026?

Based on GuruFocus' analysis, Cosciens Biopharma stock appears to be overvalued. The current stock price of $7.35 is trading 10.5% above its estimated GF Value™ of $6.65. GuruFocus considers Cosciens Biopharma to be Modestly Overvalued.

Key valuation signals for CSCIF:

  • Change In Inventory: $0.84 Mil
  • GF Value™: $6.65 vs. price of $7.35 (10.5% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the CSCIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosciens Biopharma Business Description

Other Exchanges ET8:GermanyCSCI:Canada
Address C/o Borden Ladner Gervais Llp, Suite 3400, 22 Adelaide Street West, Toronto, ON, CAN, M5H 4E3
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing pharmaceutical and diagnostic products and active ingredients for the healthcare and cosmetics industries. It operates through two segments: Active Ingredient and Biopharmaceutical. The Active Ingredient segment, which generates maximum revenue, focuses on plant-based ingredients derived from oats and other renewable resources, including oat beta glucan, oat oil, and avenanthramides. The Biopharmaceutical segment focuses on the development and commercialization of therapeutics and diagnostic tests, including its product Macrilen, and advancing a pre-clinical pipeline targeting unmet medical needs, particularly in rare or orphan indications. It operates in Canada, Germany, the United States, and Austria.
49GF Score

Get the complete analysis for CSCIF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.35
Price
$6.65
GF Value